A Functional Test to Assess Fluid Status During Lung Protective Ventilation Strategies
Development of a Functional Test to Assess Fluid Status During Lung Protective Ventilation Strategies in the Operating Room.
1 other identifier
observational
48
1 country
1
Brief Summary
Dynamic preload indices, such as pulse pressure variation (PPV) and stroke volume variation (SVV) are generally accepted as accurate indicator of fluid responsiveness in mechanically ventilated patients. Because SVV and PPV are generated by the pressure transmitted from the airways to the pleural and pericardial spaces, their reliability is limited in patients receiving low tidal volume (VT) ventilation and in those with a driving pressure lower than 20 cm H2O. Lung-protective ventilation using low VT with positive end expiratory pressure (PEEP) has recently been demonstrated to significantly improve postoperative outcome, and its application is gradually increasing in surgical patients. However, protective ventilation alters the predictability of dynamic preload indices and thus limits their use in the operating theatre. Lung recruitment maneuvers (LRMs), used to reopen collapsed lung, and PEEP have been proposed as the key components of lung-protective ventilation strategy. LRM increases intrathoracic pressure, which in turn causes a transient decrease in stroke volume (SV) and arterial pressure; this may depend on preload status. Interestingly, recent study reported that the augmented PPV during LRM using vital capacity maneuver (VCM, continuous positive airway pressure of 30 cm H2O for 10 s) could predict preload responsiveness under open chest condition. Investigators hypothesized that the augmented PPV and SVV by a stepwise LRM with incremental PEEP could represent a functional test to suggest preload responsiveness and, therefore, predict fluid responsiveness. The aims of the current study were (1) to assess the ability of augmented PPV and SVV during stepwise LRM-induced to predict fluid responsiveness in mechanically ventilated patients in the operating room, (2) to assess the ability of stepwise LRM-induced decrease in SV (ΔSV-LRM) to predict fluid responsiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2019
CompletedStudy Start
First participant enrolled
October 7, 2019
CompletedFirst Posted
Study publicly available on registry
October 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedJanuary 29, 2026
January 1, 2026
2.1 years
October 2, 2019
January 28, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
PPV_augmented
augmented pulse pressure variation by lung recruitment maneuver
During the last 5 second of lung recruitment maneuver
SVV_augmented
augmented stroke volume variation by lung recruitment maneuver
During the last 5 second of lung recruitment maneuver
Secondary Outcomes (2)
ΔSV_LRM
During the last 5 second of lung recruitment maneuver
ΔETCO2_LRM
During the last 5 second of lung recruitment maneuver
Interventions
The ventilator was switched to pressure control ventilation, inspiratory time was increased to 50%, the peak inspiratory pressure gradient (above PEEP) was set at 15cm H2O, and PEEP was progressively increased to obtain a stepwise increase of peak inspiratory to 20, 25, and 30 cm H2O every three breaths. The final recruiting pressure of 30 cm H2O was applied for six breaths.
Eligibility Criteria
tertiary care center
You may qualify if:
- Adult patients receiving laparotomy and lung protective ventilation
You may not qualify if:
- preoperative arrhythmia
- Severe bradycardia
- Moderate to severe valvular disease
- left ventricular ejection fraction \< 50%
- Poorly controlled hypertension (systolic BP \> 160 mmHg)
- Patients with renal insufficiency (creatinine \> 1.5 mg/dL)
- Moderate to severe liver disease
- BMI \>.30 or \< 15 kg/ m2
- preexisting pulmonary disease
- FEV1 \< 60% of predicted value
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kangnam Sacred Heart Hospital, Hallym University College of Medicine
Seoul, South Korea
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 2, 2019
First Posted
October 8, 2019
Study Start
October 7, 2019
Primary Completion
October 31, 2021
Study Completion
October 31, 2021
Last Updated
January 29, 2026
Record last verified: 2026-01